comparemela.com

Latest Breaking News On - Healthcare support services - Page 6 : comparemela.com

Stocks to Watch: Sanmina, Cidara, Calix, Arcus Biosciences

By Sabela Ojea Sanmina forecast second-quarter results ahead of expectations and said it was expecting improvements in the second half of the year. Shares of.

Sabela ojeaGilead sciencesHealthcare products regulatory agencyArticle normalBiotechnology servicesComputers consumer electronicsApplications softwarePassive componentsScientific research servicesHealthcare life sciencesBusiness consumer servicesEnterprise management softwareIndustrial electronicsIndustrial goodsMedical research servicesDrug discovery development

Elon Musk s Neuralink Implants First Brain Chip in Human Big Tech Will Be Watching

Elon Musk said late Monday that the first person has received an implant from his brain-chip startup Neuralink and is “recovering well.”

Stephen hawkingElon muskSteve jurvetsonCallum keownArticle normalScientific research servicesHealthcare life sciencesBusiness consumer servicesMedical research servicesHealthcare support servicesDiagnostic medical research servicesNorth americaRapid responseLife sciencesConsumer services

Elon Musk says Neuralink has implanted brain chip into a human for first time

Elon Musk said Monday that his company Neuralink has conducted its first brain implant in a human patient.

Elon muskStephen hawkingDrug administrationArticle normalComputers electronicsMedical equipment suppliesScientific research servicesHealth careBusiness consumer servicesMedical research servicesHealthcare support servicesDiagnostic medical research servicesMedical devices apparatusOrthopedic prosthetic implants devicesDiagnostic therapeutic devicesCorporate industrial news

Vertex Unveils Strong Data on Opioid Alternative

If approved, it would be the first new pain medicine in decades, and could provide an alternative to opioids.

Stuart arbuckleDavid risingerJosh nathan kazisSalveen richterDavid altshulerDrug administrationVertex pharmaceuticalsGoldman sachsArticle normalScientific research servicesHealthcare life sciencesBusiness consumer servicesSpecialized drugs medicationsMedical research servicesDrug discovery developmentHealthcare support services

HVIVO Revenue Rose on Strong Trials Delivery, Consulting Services; To Start Paying Dividend

By Anthony O. Goriainoff hVIVO said revenue rose for the year and was ahead of market expectations due to strong trials delivery and consulting services, and.

City ofUnited kingdomAnthonyo goriainoffOpen orphanArticle normalScientific research servicesHealthcare life sciencesAccounting consultingBusiness consumer servicesBusiness consultancyMedical research servicesDrug discovery developmentHealthcare support servicesDiagnostic medical research servicesFinancial performanceSales figures

vimarsana © 2020. All Rights Reserved.